Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Items 601–700 of 844
N-Glycosylation Patterns across the Age-Related Macular Degeneration Spectrum
Bućan, I., Herman, J. Š., Tomić, I. J., Gornik, O., Vatavuk, Z., Bućan, K., Lauc, G., & Polašek, O. (2022) · Molecules · doi:10.3390/molecules27061774 · Cited by 8
Sénard, T., Flouri, I. D., Vučković, F., Papadaki, G., Goutakoli, P., Banos, A., Pučić‐Baković, M., Pezer, M., Bertsias, G. K., Lauc, G., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02897-5 · Cited by 8
Storage stability and HILIC-UHPLC-FLR analysis of immunoglobulin G N-glycome from saliva
Radovani, B., Lauc, G., & Gudelj, I. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04682-y · Cited by 8
“Glycans with exposed mannose are recognized and bound by mannose-binding lectin (MBL), initiating the lectin pathway of complement activation [28].”
BackgroundGlycoproteomics in Health and Disease
Struwe, W. B., Cosgrave, E. F. J., Byrne, J. C., Saldova, R., & Rudd, P. M. (2010) · Springer eBooks · doi:10.1007/978-90-481-9355-4_1 · Cited by 8
Self-citationWang, H., Zhang, J., Dong, J., Hou, M., Pan, W., Bu, D., Zhou, J., Zhang, Q., Wang, Y., Zhao, K., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103649 · Cited by 8
Glycosylation-dependent antitumor therapeutic monoclonal antibodies
Zhang, Y., Fan, C., Zhang, L., & Ma, X. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.004 · Cited by 9
(2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0 · Cited by 8
Investigations on the Involvement of the Lectin Pathway of Complement Activation in Anaphylaxis
Windbichler, M., Echtenacher, B., Takahashi, K., Ezekowitz, R. A. B., Schwaeble, W., Jenseniuis, J. C., & Männel, D. N. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000094177 · Cited by 8
Mannose-binding lectin deficiencies in infectious and inflammatory disorders
Guardia, A., & Lozano, F. (2003) · Reviews in Medical Microbiology · doi:10.1097/00013542-200304000-00001 · Cited by 8
“This IgG lacks the two galactose units at the Ca2 domain and presents instead N-acetyl glucosamine, which could allow MBL binding and complement activation with subsequent release of inflammatory mediators and chronic inflammation of the synovial membrane [66].”
BackgroundScreening Neutral and Acidic IgG N-Glycans by High Density Electrophoresis
Frears, E. R., Merry, A. H., & Axford, J. S. (1999) · Glycoconjugate Journal · doi:10.1023/a:1007014028905 · Cited by 8
Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease
Azzam, T., Bournazos, S., Gunduz, H., Adams, T. M., Flowers, M. W., Niejadlik, E. G., Duong, V., Brown, T. J., Roberts, A. M., Sastre, D. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67070-3 · Cited by 7
Therapeutic proteins: facing the challenges of glycobiology
Albrecht, S., Hilliard, M., & Rudd, P. M. (2014) · Journal of Health Policy & Outcomes Research · doi:10.7365/jhpor.2014.5.2 · Cited by 7
Self-citationComplement Activation by Nanomaterials
Simberg, D., & Moghimi, S. M. (2020) · Molecular and integrative toxicology · doi:10.1007/978-3-030-33962-3_6 · Cited by 7
Activation and Inhibition of Complement by Immunoglobulins
Bašta, M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8056-5_24 · Cited by 7
Tang, W., Matsumoto, A., Shikata, K., Takeuchi, F., Konishi, T., Nakata, M., & Mizuochi, T. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006971318736 · Cited by 7
Plavša, B., Rudman, N., Pociot, F., & Gornik, O. (2025) · Biomedicines · doi:10.3390/biomedicines13051206 · Cited by 6
“This makes N -glycans important modulators of effector functions of IgG such as ADCC and activation of the complement system via both classical and mannose-binding lectin pathway [9].”
Journeys in Science: Glycobiology and Other Paths
Dwek, R. A. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-041612-095236 · Cited by 6
Self-citationHigh-resolution physicochemical characterization of different intravenous immunoglobulin products
Washburn, N., Meccariello, R., Hu, S., Hains, M., Bhatnagar, N., Sarvaiya, H., Kapoor, B. M. L., Schaeck, J. J., Pino, I., Manning, A. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181251 · Cited by 6
Zhao, C., Sun, Z., Wang, S., Zhang, J., Liu, J., Chen, L., Lu, G., Yu, Y., & Gao, Y. (2024) · European Thyroid Journal · doi:10.1530/etj-24-0156 · Cited by 6
“In rheumatoid arthritis, G0 glycan enabled IgG to activate complement via the lectin pathway (32).”
Sanes, J. T., Costello, C. E., & Steere, A. C. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42465 · Cited by 6
Altered glycosylation profiles of serum IgG in Takayasu arteritis
Liu, L., Li, J., Yang, Y., Hu, C., & Tian, X. (2023) · European journal of medical research · doi:10.1186/s40001-023-01035-4 · Cited by 6
Developing microRNAs as engineering tools to modulate monoclonal antibody galactosylation
Klingler, F., Schlossbauer, P., Naumann, L., Handrick, R., Hesse, F., Neusüß, C., & Otte, K. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28616 · Cited by 6
“…in addition, these galactoses are the link for the attachment of terminal sialic acids (Ackerman et al., 2013; Hodoniczky et al., 2005; Kumpel et al., 1995; Majewska et al., 2020; Malhotra et al., 1995; Peipp et al., 2008; Thomann et al., 2016; Winkelhake & Nicolson, 1976; Wright et al., 2000).”
BackgroundKanoh, Y., Egawa, S., Baba, S., & Akahoshi, T. (2009) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20302 · Cited by 6
Rebello, O. D., Gardner, R. A., Urbanowicz, P. A., Bolam, D. N., Crouch, L. I., Falck, D., & Spencer, D. I. R. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09953-9 · Cited by 6
“Additionally, these agalactosylated glycans further induce a pro-inflammatory response via activation of the complement system through interaction with the mannose binding proteins [16].”
BackgroundDetermination of Antibody Glycosylation by Mass Spectrometry
Jäger, C., Ferrara, C., Umaña, P., Zeck, A., Regula, J. T., & Koll, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-931-0_13 · Cited by 6
Interactions Outside the Antigen-Combining Site
Nezlin, R. S. (1998) · Elsevier eBooks · doi:10.1016/b978-012517970-6/50006-0 · Cited by 6
N-Glycosylation of IgG Immunoglobulin and its clinical significance
Παπακωνσταντίνου, Μ., Dryllis, G., Efstathopoulou, M., Vlachopanou, D., Kechriotis, M., & Valsami, S. I. (2019) · Journal of Biomedicine · doi:10.7150/jbm.33922 · Cited by 6
“(32) In rheumatoid arthritis, it has been found that there are changes in the N-linked oligosaccharide galactosylation of the Fc portion of serum IgG, with a marked increase in the percentage of IgG lacking galactose (GO form).”
BackgroundVickers, M. A., & Barker, R. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00047-6 · Cited by 6
Kimberly, R. P. (1999) · KARGER eBooks · doi:10.1159/000060483 · Cited by 6
Chapter 6 Glycoproteins in inflammatory bowel disease
Tomana, M. (1996) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60292-6 · Cited by 6
Naturally Presented MHC Ligands Carrying Glycans
Dengjel, J., & Stevanović, S. (2006) · Transfusion Medicine and Hemotherapy · doi:10.1159/000090194 · Cited by 6
Autoimmunity – Rheumatoid Arthritis
Taylor, P. C. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50304-4 · Cited by 6
Hypothetical Pathogenetic Model of Membranous Nephropathy
Zdravkova, I., Tilkiyan, E. E., Bozhkova, D., Kuskunov, T., Ronchev, Y., & Kirilov, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052206 · Cited by 5
“They relate this to data from Malhotra et al., who found that IgG autoantibodies lacking the terminal galactose residue at position Asn 297 of the constant fragment (Fc) were able to bind and activate MBL [27].”
Lymphocyte-mediated immune responses to Leishmania infection
Engwerda, C. R., Kaye, P. M., & Stäger, S. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01294-2 · Cited by 5
IgG glycosylation profiling of systemic lupus erythematosus using lectin microarray
Wu, Y., Wang, M., Hu, C., Zhang, S., Zhao, J., Wang, Q., Xu, D., Tian, X., Zhao, Y., Zeng, X., et al. (2025) · Lupus Science & Medicine · doi:10.1136/lupus-2024-001413 · Cited by 5
“Although IgG-GO has been reported to lack C1q-binding properties, 40 42 some researchers suggest that it may activate complement through the lectin pathway.”
Sen, W. A. N. G., Gao, Z., Liu, H., Meng, P., Wu, C., Lammi, M. J., & Guo, X. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1903-137 · Cited by 5
“More importantly, shifts in the glycosylation patterns have been identified in diseases, such as in IgG of the serum of rheumatoid arthritis patients [13], which was later found to be responsible for the activation of the complement system [14].”
BackgroundYu, X., Baruah, K., Scanlan, C. N., & Crispin, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00010-8 · Cited by 5
Increased sensitivity of Apolipoprotein E knockout mice to swainsonine dependent immunomodulation
Scott, D. W., Black, L. L., Vallejo, M. O., Kabarowski, J. H. S., & Patel, R. P. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.02.011 · Cited by 5
Liu, D., Jian-ying, Z., & Zhong-xiang, N. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00465-07 · Cited by 5
“In addition, though, the protein cytokeratin, when it is exposed on ischemic endothelial cells (12), also activates this pathway, as can antibodies bearing a specific form of agalactosyl carbohydrate designated G0 (73).”
BackgroundB Cells Producing Pathogenic Autoantibodies
Zou, Y.-R., & Diamond, B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00023-0 · Cited by 5
Güneşaçar, R., Korkmaz, D. T., YILDIRIM, A., & Eryılmaz, N. (2011) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2010-19722 · Cited by 5
A Longitudinal Study of Glycosylation of a Human IgG3 Paraprotein in a Patient with Multiple Myeloma
Farooq, M., Takahashi, N., Drayson, M. T., Lund, J., & Jefferis, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5383-0_10 · Cited by 5
IgA Nephropathy and Related Diseases
Emancipator, S. N., Mestecky, J., & Lamm, M. E. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50096-6 · Cited by 5
Structural alterations in outer arms of IgG oligosaccharides in patients with Werner syndrome
Kuroda, Y., Shikata, K., Takeuchi, F., Akazawa, T., Kojima, N., Nakata, M., Mizuochi, T., & Goto, M. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.01.001 · Cited by 5
Ho, C.-H., Tsai, H., Lee, C.-Y., Huang, L., Chien, R., Wu, I., Chiu, Y., Liu, W., Cheng, P., Chang, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02158-5 · Cited by 5
Antibody and Protein Glycosylation in Health and Disease
Arrol, H. P., & Jefferis, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012459460-9/50013-5 · Cited by 5
Rhodes, J. M., Campbell, B. J., & Yu, L. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0002151.pub2 · Cited by 5
Zdravkova, I., Tilkiyan, E. E., & Bozhkova, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147659 · Cited by 4
“The authors related this to the data of Malhotra et al., who found that IgG autoantibodies lacking the terminal galactose residue at position Asn 297 of the constant fragment (Fc) were able to bind and activate MBL [17].”
ResultSun, S., Hao, J., Yu, C., Liu, H., Guan, Q., Wang, Y., Wang, J., Wang, X., Zhang, M., Zan, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07236-1 · Cited by 4
Yan, R., Wang, C., Zhao, X., Wang, Y., Liu, M., Shí, X., Chen, H., & Li, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1758338 · Cited by 4
Glycosylation in autoimmune diseases: A bibliometric and visualization study
Deng, G., Chen, X., Le, S., Wu, Q., & Wang, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30026 · Cited by 4
“In 1995, an article showed that the absence of IgG Fc galactosylation induced the complement system and promoted RA inflammation [37].”
BackgroundMolecular Variants Characterization in Protein Therapeutics Development
Ludwig, R. T., Bongers, J., Tao, L., Huang, Y., Fu, J., Wu, W., Liu, P., Song, H., & Russell, R. J. (2013) · Springer eBooks · doi:10.1007/978-1-4419-7862-2_6 · Cited by 4
Petit, M. A., Walet-Balieu, M.-L., Schapman, D., Golinski, M.-L., Burel, C., Barray, M., Drouot, L., Maho‐Vaillant, M., Hébert, V., Boyer, O., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101411 · Cited by 4
“Interestingly, altered N-glycosylation of IgG4 can activate complement via the lectin pathway in membranous nephropathy [13], as well as in rheumatoid arthritis (RA) [14].”
BackgroundGlycosylation of Antibody Molecules
Jefferis, R. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch8 · Cited by 4
Medical Relevance, State-of-the-Art and Perspectives of “Sweet Metacode” in Liquid Biopsy Approaches
Pinkeová, A., Košútová, N., Jáné, E., Lorencová, L., Bertóková, A., Bertók, T., & Tkáč, J. (2024) · Diagnostics · doi:10.3390/diagnostics14070713 · Cited by 4
Chintalacharuvu, S. R., Urankar-Nagy, N., Petersilge, C. A., Abdul‐Karim, F. W., & Emancipator, S. N. (2001) · PubMed · Cited by 4
Prenc, E., Pulanić, D., Pučić‐Baković, M., Ugrina, I., Desnica, L., Milošević, M., Pirsl, F., Mitchell, S. A., Rose, J. J., Vrḫovac, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633214 · Cited by 4
Human IgG Glycosylation in Inflammation and Inflammatory Disease
Mimura, Y., & Jefferis, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00047-x · Cited by 4
Dinasarapu, A. R. (2013) · eScholarship (California Digital Library) · doi:10.6072/h0.mp.a004276.01 · Cited by 4
Glycobiology: a Quantum Leap in Carbohydrate Chemistry
Dwek, R. A. (1996) · Foundations of modern biochemistry · doi:10.1016/s1874-5660(96)80023-2 · Cited by 4
Self-citationAntibody‐Complement Interaction
Mershon, K. L., & Morrison, S. L. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch16 · Cited by 4
Glycobiology of the Immune System
Hounsell, E. F. (2000) · Wiley eBooks · doi:10.1002/9783527618255.ch102 · Cited by 4
Jefferis, R. (2002) · Cell engineering · doi:10.1007/0-306-47525-1_3 · Cited by 4
Cosgrave, E. F. J., Struwe, W. B., Kattla, J. J., Campbell, M. P., Wormald, M. R., & Rudd, P. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00051-9 · Cited by 4
Self-citationA Convenient Microscale Colorimetric Method for Terminal Galactose on Immunoglobulins
Raju, T. S., Nayak, N., Briggs, J. B., O'Connor, J. V., & Lerner, L. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1009 · Cited by 4
Immunoglobulin G Glycosylation in Diseases
Pezer, M. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_13 · Cited by 4
Characterization of surfactant proteins in porcine Eustachian tube
Paananen, R. (2001) · Cited by 4
Sim, R. B. (1998) · Elsevier eBooks · doi:10.1006/rwei.1999.0161 · Cited by 4
Self-citationKunkel, J. P. (2002) · Mspace (University of Manitoba) · Cited by 4
Lectin-reactive Anti-α-Gal in Patients with Crohnʼs Disease: Correlation with Clinical Phenotypes
Safaie, P., Ham, M., Kuang, P., Mehta, A. S., Wang, M., Cheifetz, A. S., Robson, S. C., Lau, D., Block, T. M., & Moss, A. C. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435437.76741.cb · Cited by 3
“The absence of galactose on one or both arms of this glycan moiety has been shown to activate complement and enhance inflammation in experimental models.(18,19) We report that patients with CD exhibit elevated serum levels of anti-a-Gal antibodies that lack galactose at this N-glycosylation site, when compared with HC.”
BackgroundNon B Cell-Derived Immunoglobulins in Intestinal Tract
Geng, Z., Wu, L., Wang, Q., Ma, J., & Shi, Z. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-0511-5_11 · Cited by 3
Firdaus, N. H. W., Mallick, B., Nandakumar, K. S., & Shakya, A. K. (2025) · Journal of The Royal Society Interface · doi:10.1098/rsif.2025.0138 · Cited by 3
“The involvement of the lectin pathway is also confirmed in the establishment of RA by changing IgG glycosylation that causes enhanced binding of MBL proteins, activating the complement cascade [60].”
Production of Monoclonal Antibodies in Glycoengineered Pichia pastoris
Zha, D., Linden, T. O., & Potgieter, T. I. (2011) · Cell engineering · doi:10.1007/978-94-007-1257-7_4 · Cited by 3
Roles for Glycosylation in Receptor-Ligand Interactions in the Immune System
Rudd, P. M., Merry, A. H., & Dwek, R. A. (2005) · Springer eBooks · doi:10.1007/1-4020-3103-3_4 · Cited by 3
“Functional recognition of IgG0 by the multiply presented carbohydrate recognition domains (CRDs) of MBL depends on multiple presentation of IgG0 glycans [13].”
BackgroundSelf-citationYin, X., Li, X., Mu, L., Han, K., Wu, H., Wu, L., Wang, A., Ying, W., & Ye, J. (2020) · Talanta · doi:10.1016/j.talanta.2020.121346 · Cited by 3
Yin, X., Li, X., Mu, L., Bai, H., Yang, Y., Chen, N., Wu, L., Fu, S., Li, J., Ying, W., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100921 · Cited by 3
Changes in the N-glycosylation of porcine immune globulin G during postnatal development
Zlatina, K., Isernhagen, L., Galuska, C. E., Muráni, E., & Galuska, S. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1361240 · Cited by 3
“This includes pro-in fl ammatory responses such as antibody-dependent cellular phagocytosis, antibody-dependent cell-mediated cytotoxicity (2 – 7), complement-dependent cytotoxicity (8, 9), and anti-in fl ammatory responses (10, 11).”
BackgroundYuka, M., Otsuka, T., Waguri, Y., Matsui, N., Asai, K., Kato, T., Araki, H., Tsukamoto, Y., & Takahashi, N. (1998) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.25.131 · Cited by 3
“The second possibility may be involved in the degenerative process of agalactosyl RA-IgG, which is speculated to activate complement through the lectin pathway by interacting with mannose-binding protein (MBP) and MBP-associated serine proteases [25].”
BackgroundCosgrave, E. F. J., Kattla, J. J., Campbell, M. P., Struwe, W. B., Wormald, M. R., & Rudd, P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.09031-2 · Cited by 3
Self-citationThe Stability of Lymphocytic β1,4‐Galactosyltransferase Expression During Pregnancy and Lactation
JEDDI, P. A., Keusch, J. J., Lydyard, P. M., & Delves, P. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-379.x · Cited by 3
Beck, A. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.06.050 · Cited by 3
Kimura, S., Numaguchi, M., Kaizu, T., Kim, D., Takagi, Y., & Gomi, K. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00289-8 · Cited by 3
Human IgG Glycosylation in Inflammation and Inflammatory Disease
Jefferis, R. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00099-4 · Cited by 4
El-Aghbary, D. A. (2018) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v3i2.138 · Cited by 3
Editorial: Sweets Are Good for You: Fine Tuning Antibodies via Glycosylation
Nigrovic, P. A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38080 · Cited by 3
Gardinassi, L. G., & Santos, I. K. F. D. M. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1669-0 · Cited by 3
“ferent FcR affects effector mechanisms of antibodymediated immunity: interactions of IgGs with type I FcR (the canonical FcγRI, FcγRIIa, FcγRIIb, FcγRIIc, FcγRIIIa, FcγRIIIb) or type II FcR (DC-SIGN and CD23) [36]; or with mannan-binding lectin [37] and the complement component C1q [38] are also regulated by the patte…”
Approches de glycomique appliquées à l'étude des pathologies métaboliques des glycoprotéines
Faid, V. (2008) · theses.fr (ABES) · doi:10.70675/db063bc9z333dz49ecz9fadzf2db91138fbd · Cited by 3
Zouali, M. (2026) · Immunology · doi:10.1111/imm.70178 · Cited by 2
Molecular and Cellular Pathways Involved in the Anti-inflammatory Activity of IgG
Nimmerjahn, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7107-3_5 · Cited by 2
Glyco-engineering of Fc Glycans to Enhance the Biological Functions of Therapeutic IgGs
Raju, T. S., Knight, D. M., & Jordan, R. E. (2010) · Springer eBooks · doi:10.1007/978-90-481-9355-4_2 · Cited by 2
Role of Antibody Glycosylation in Health, Disease, and Therapy
Nimmerjahn, F. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_744 · Cited by 3
Glycosylation of Antibody Molecules
Jefferis, R., Goodall, M. D., Тищенко, В. М., NASH, P. H., & Lund, J. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1885-3_14 · Cited by 2
Production of Antibodies in Plants
Cox, K. M., Regan, J. T., Sterling, J. D., Wingate, V. P. M., & Dickey, L. F. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch29 · Cited by 2
Targeting Complement in Rheumatoid Arthritis
Biro, E., Tak, P. P., Sturk, A., Hack, C. E., & Nieuwland, R. (2008) · Current Rheumatology Reviews · doi:10.2174/157339708786263924 · Cited by 2
Inherited Complement Deficiencies
Sullivan, K. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00085-9 · Cited by 2
Vickers, M. A., & Barker, R. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00046-0 · Cited by 2
Glycoproteomics: High-Throughput Sequencing of Oligosaccharide Modifications to Proteins
Rudd, P. M., Colominas, C., Royle, L., Murphy, N., Hart, E., Merry, A. H., Heberstreit, H. F., & Dwek, R. A. (2001) · Principles and practice · doi:10.1007/978-3-642-56895-4_11 · Cited by 2
Self-citationSynthesis of Glycopeptides and Glycoproteins
Gamblin, D. P., Scanlan, E. M., & Davis, B. G. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00016-7 · Cited by 2
Novel Approaches for Glycodrug Discovery
Kondo, H. (2008) · Springer eBooks · doi:10.1007/978-3-540-30429-6_61 · Cited by 2
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.